The bill, titled H.B. No. 1474, aims to prohibit the retail sale and provision of certain over-the-counter weight loss drugs and dietary supplements to individuals under 18 years of age. It introduces a new Chapter 446 to the Health and Safety Code, which defines key terms such as "dietary supplement," "over-the-counter weight loss drug," and "retailer." The bill outlines specific responsibilities for retailers, including ensuring that these products are not directly accessible to customers and requiring identification verification for purchasers who appear to be underage. Additionally, it establishes civil penalties for violations, allowing the attorney general to enforce these provisions.

The legislation also includes provisions for remote sales, mandating that sellers use delivery methods that require age verification upon receipt. A civil penalty of up to $500 per violation is stipulated, with the attorney general authorized to take legal action to enforce compliance. The bill provides an affirmative defense for sellers if they can demonstrate that a buyer presented valid identification. Importantly, compliance with the new regulations will not be required until December 1, 2025, and the act is set to take effect on September 1, 2025.

Statutes affected:
Introduced: ()